Long-acting injectable paliperidone palmitate for schizophrenia

2195975039_d957bacec2_b

Tracey Roberts summarises a recent RCT of the efficacy and safety of paliperidone palmitate 3-month formulation for patients with schizophrenia.

[read the full story...]

Psychotropic medication in pregnancy: new evidence may help achieve a safe balance

pregnant with ipad

Joanne Wallace considers a recent health technology assessment on the risks and benefits of psychotropic medication in pregnancy, which supports previous associations between valproate and adverse child outcomes.

[read the full story...]

Mental illness, challenging behaviour and psychotropic drugs #UCLJournalClub

1280px--The_Conversation-,_1963_-_NARA_-_558908

Join us at 2-3pm on Wednesday 18th May for the #UCLJournalClub, which will be live broadcasted on YouTube and live tweeted by the @LearningDisElf

[read the full story...]

Antipsychotics for treatment-resistant schizophrenia

4655344761_e526e9afff_b

Murtada Alsaif summarises a recent network meta-analysis, which looks at the efficacy, acceptability and tolerability of antipsychotics for treatment-resistant schizophrenia.

[read the full story...]

Prognosis of brief psychotic episodes

3917186281_bb24ceabb8_o

Samei Huda presents the findings of a new meta-analysis, which explores the prognostic significance of competing ways of defining and measuring brief psychotic episodes.

[read the full story...]

Commonly prescribed psychiatric drugs: do they work?

4932655275_7811863fe8_o

John Baker summarises a review of commonly prescribed medication that covers seven psychiatric drugs, including antidepressants, antipsychotics, benzodiazepines, amphetamines, methylphenidate and cholinesterase inhibitors.

[read the full story...]

Aripiprazole for treatment-resistant depression in older adults

16407815325_c4bc936054_k

Sarsha Wilson publishes her debut blog about a recent RCT on the efficacy, safety and tolerability of augmentation pharmacotherapy with aripiprazole for treatment-resistant depression in later life.

[read the full story...]

Lamotrigine, quetiapine and folic acid for bipolar depression: the CEQUEL trial

15802794635_256de371d5_k

Michael Ostacher considers the findings of the CEQUEL trial, which asks: Does lamotrigine treat bipolar depression when added to quetiapine, and does adding folic acid help any more?

[read the full story...]

Lithium for schizophrenia: Cochrane find lack of evidence to support its use

8407060410_e06b0d3e09_k

Raphael Underwood presents a new Cochrane review of lithium for schizophrenia, which assesses the use of lithium as a monotherapy and also in combination with antipsychotics.

[read the full story...]

Biological pathways, antipsychotics and schizophrenia

1622916980_ba3ea68e3e_b

Murtada Alsaif summarises a small cohort study that uses shotgun mass spectrometry proteomic profiling to unravel the molecular pathways involved with antipsychotic response in people with schizophrenia.

[read the full story...]